author_facet Nita, Marcelo Eidi
Eliaschewitz, Freddy G.
Ribeiro, Eliane
Asano, Elio
Barbosa, Elias
Takemoto, Maíra
Donato, Bonnie
Rached, Roberto
Rahal, Elaine
Nita, Marcelo Eidi
Eliaschewitz, Freddy G.
Ribeiro, Eliane
Asano, Elio
Barbosa, Elias
Takemoto, Maíra
Donato, Bonnie
Rached, Roberto
Rahal, Elaine
author Nita, Marcelo Eidi
Eliaschewitz, Freddy G.
Ribeiro, Eliane
Asano, Elio
Barbosa, Elias
Takemoto, Maíra
Donato, Bonnie
Rached, Roberto
Rahal, Elaine
spellingShingle Nita, Marcelo Eidi
Eliaschewitz, Freddy G.
Ribeiro, Eliane
Asano, Elio
Barbosa, Elias
Takemoto, Maíra
Donato, Bonnie
Rached, Roberto
Rahal, Elaine
Revista da Associação Médica Brasileira
Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
General Medicine
author_sort nita, marcelo eidi
spelling Nita, Marcelo Eidi Eliaschewitz, Freddy G. Ribeiro, Eliane Asano, Elio Barbosa, Elias Takemoto, Maíra Donato, Bonnie Rached, Roberto Rahal, Elaine 0104-4230 Elsevier BV General Medicine http://dx.doi.org/10.1016/s0104-4230(12)70198-7 Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system Revista da Associação Médica Brasileira
doi_str_mv 10.1016/s0104-4230(12)70198-7
facet_avail Online
Free
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMDEwNC00MjMwKDEyKTcwMTk4LTc
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMDEwNC00MjMwKDEyKTcwMTk4LTc
institution DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint Elsevier BV, 2012
imprint_str_mv Elsevier BV, 2012
issn 0104-4230
issn_str_mv 0104-4230
language English
mega_collection Elsevier BV (CrossRef)
match_str nita2012costeffectivenessandbudgetimpactofsaxagliptineasadditionaltherapytometforminforthetreatmentofdiabetesmellitustype2inthebrazilianprivatehealthsystem
publishDateSort 2012
publisher Elsevier BV
recordtype ai
record_format ai
series Revista da Associação Médica Brasileira
source_id 49
title Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
title_unstemmed Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
title_full Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
title_fullStr Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
title_full_unstemmed Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
title_short Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
title_sort cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the brazilian private health system
topic General Medicine
url http://dx.doi.org/10.1016/s0104-4230(12)70198-7
publishDate 2012
physical 294-301
description
container_issue 3
container_start_page 294
container_title Revista da Associação Médica Brasileira
container_volume 58
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792330464493568003
geogr_code not assigned
last_indexed 2024-03-01T13:25:29.833Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Cost-effectiveness+and+budget+impact+of+saxagliptine+as+additional+therapy+to+metformin+for+the+treatment+of+diabetes+mellitus+type+2+in+the+Brazilian+private+health+system&rft.date=2012-05-01&genre=article&issn=0104-4230&volume=58&issue=3&spage=294&epage=301&pages=294-301&jtitle=Revista+da+Associa%C3%A7%C3%A3o+M%C3%A9dica+Brasileira&atitle=Cost-effectiveness+and+budget+impact+of+saxagliptine+as+additional+therapy+to+metformin+for+the+treatment+of+diabetes+mellitus+type+2+in+the+Brazilian+private+health+system&aulast=Rahal&aufirst=Elaine&rft_id=info%3Adoi%2F10.1016%2Fs0104-4230%2812%2970198-7&rft.language%5B0%5D=eng
SOLR
_version_ 1792330464493568003
author Nita, Marcelo Eidi, Eliaschewitz, Freddy G., Ribeiro, Eliane, Asano, Elio, Barbosa, Elias, Takemoto, Maíra, Donato, Bonnie, Rached, Roberto, Rahal, Elaine
author_facet Nita, Marcelo Eidi, Eliaschewitz, Freddy G., Ribeiro, Eliane, Asano, Elio, Barbosa, Elias, Takemoto, Maíra, Donato, Bonnie, Rached, Roberto, Rahal, Elaine, Nita, Marcelo Eidi, Eliaschewitz, Freddy G., Ribeiro, Eliane, Asano, Elio, Barbosa, Elias, Takemoto, Maíra, Donato, Bonnie, Rached, Roberto, Rahal, Elaine
author_sort nita, marcelo eidi
container_issue 3
container_start_page 294
container_title Revista da Associação Médica Brasileira
container_volume 58
description
doi_str_mv 10.1016/s0104-4230(12)70198-7
facet_avail Online, Free
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMDEwNC00MjMwKDEyKTcwMTk4LTc
imprint Elsevier BV, 2012
imprint_str_mv Elsevier BV, 2012
institution DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 0104-4230
issn_str_mv 0104-4230
language English
last_indexed 2024-03-01T13:25:29.833Z
match_str nita2012costeffectivenessandbudgetimpactofsaxagliptineasadditionaltherapytometforminforthetreatmentofdiabetesmellitustype2inthebrazilianprivatehealthsystem
mega_collection Elsevier BV (CrossRef)
physical 294-301
publishDate 2012
publishDateSort 2012
publisher Elsevier BV
record_format ai
recordtype ai
series Revista da Associação Médica Brasileira
source_id 49
spelling Nita, Marcelo Eidi Eliaschewitz, Freddy G. Ribeiro, Eliane Asano, Elio Barbosa, Elias Takemoto, Maíra Donato, Bonnie Rached, Roberto Rahal, Elaine 0104-4230 Elsevier BV General Medicine http://dx.doi.org/10.1016/s0104-4230(12)70198-7 Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system Revista da Associação Médica Brasileira
spellingShingle Nita, Marcelo Eidi, Eliaschewitz, Freddy G., Ribeiro, Eliane, Asano, Elio, Barbosa, Elias, Takemoto, Maíra, Donato, Bonnie, Rached, Roberto, Rahal, Elaine, Revista da Associação Médica Brasileira, Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system, General Medicine
title Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
title_full Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
title_fullStr Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
title_full_unstemmed Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
title_short Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
title_sort cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the brazilian private health system
title_unstemmed Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
topic General Medicine
url http://dx.doi.org/10.1016/s0104-4230(12)70198-7